Tag: UDCA
Primary Biliary Cholangitis Treatment: What Works in 2026
As of 2026, PBC treatment has shifted dramatically with the withdrawal of Ocaliva and the rise of seladelpar and elafibranor. Learn how UDCA remains first-line, what the new options do, and how to navigate treatment decisions.
read morerecent posts
Nasal congestion from overused decongestant sprays is common and reversible. Learn how rebound congestion works, why stopping the spray is the only cure, and what actually helps you recover - backed by clinical evidence.
Published ON: 5 MarBioequivalence testing for combination products like FDCs, inhalers, and topical creams is far more complex than for single-drug generics. Regulatory, technical, and financial hurdles delay affordable access to life-saving medications.
Published ON: 13 MarSocial media is transforming how patients learn about generic drugs. From TikTok explainers to Instagram Reels, digital platforms are cutting through confusion and building trust-no brochures needed.
Published ON: 17 MarPhysicians prescribing generic medications now face rising legal liability as federal rulings shield drug manufacturers from lawsuits. Learn how to protect yourself with proper documentation and prescribing practices.
Published ON: 10 MarCounterfeit medications are a growing global threat, with millions of fake pills and injections seized each year. Real cases from 2025 reveal how dangerous these fakes are-and what we must do to stop them.
Published ON: 3 Mar